COTI-2, a novel small molecule that is active against multiple human cancer cell lines<i>in vitro</i>and<i>in vivo</i>Kowthar Y. Salim, James Koropatnick|Oncotarget|2016Cited by 152
CD5 blockade enhances ex vivo CD8 <sup>+</sup> T cell activation and tumour cell cytotoxicityFaizah Alotaibi, James Koropatnick|European Journal of Immunology|2020Cited by 41